Concepedia

E. S. Kim

ES

6

Publications

303

Citations

6

H-Index

2005

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

E. S. Kim is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2005–2013

6

Publications

6

Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients

Sao Jiralerspong, E. S. Kim, Wenli Dong et al. · Annals of Oncology · 2013 · 165 citations · Full text

, , +8

Final results of a phase II study of erlotinib, docetaxel and cisplatin in patients with recurrent/metastatic head and neck cancer

E. S. Kim, M.S. Kies, Bonnie S. Glisson et al. · Journal of Clinical Oncology · 2007 · 51 citations

, , +18

Phase II study of combination cisplatin, docetaxel and erlotinib in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC)

E. S. Kim, M.S. Kies, Bonnie S. Glisson et al. · Journal of Clinical Oncology · 2006 · 29 citations

, , +19

Phase II study of gefitinib in patients with metastatic/recurrent squamous cell carcinoma of the skin

Bonnie S. Glisson, E. S. Kim, M.S. Kies et al. · Journal of Clinical Oncology · 2006 · 26 citations

, , +16

Phase II randomized study of biomarker-directed treatment for non-small cell lung cancer (NSCLC): The BATTLE (Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination) clinical trial program

E. S. Kim, Roy S. Herbst, J. Jack Lee et al. · Journal of Clinical Oncology · 2009 · 17 citations

, , +18

Rows per page

1–5 of 6